Contravisory Investment Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-32
Closed -$17.4K 358
2024
Q2
$17.4K Sell
32
-13
-29% -$7.45K ﹤0.01% 286
2024
Q1
$28.9K Buy
45
+4
+10% +$2.43K 0.01% 262
2023
Q4
$24K Buy
+41
New +$22.9K 0.01% 269
2021
Q2
Sell
-9,877
Closed -$4.54M 271
2021
Q1
$4.54M Sell
9,877
-387
-4% -$190K 1.42% 35
2020
Q4
$5.47M Sell
10,264
-3
-0% -$1.47K 1.7% 34
2020
Q3
$4.93M Sell
10,267
-107
-1% -$52.5K 1.68% 33
2020
Q2
$4.67M Buy
+10,374
New +$4.63M 1.72% 31
2018
Q1
Sell
-9
Closed -$2K 351
2017
Q4
$2K Hold
9
﹤0.01% 321
2017
Q3
$2K Buy
+9
New +$1.77K ﹤0.01% 349

Other funds holding CHE

Contravisory Investment Management's CHE Position: Q3 2024 in Review

Contravisory Investment Management sold out of Chemed (CHE) in Q3 2024, closing a stake of 32 shares — an estimated $17.4K sold.

Contravisory Investment Management first reported a position in CHE in Q3 2017 and held it in 9 quarters. The position peaked at $5.47M in Q4 2020. 527 funds tracked by Wall St. Rank hold CHE as of Q3 2024.

  • Contravisory Investment Management reported no remaining Chemed position as of Q3 2024 after selling out during the quarter.
  • Contravisory Investment Management sold 32 Chemed shares in Q3 2024, an estimated $17.4K.
  • Contravisory Investment Management first reported a position in Chemed in Q3 2017 and held it in 9 quarters.
  • Contravisory Investment Management's Chemed position peaked at $5.47M in Q4 2020.
  • 527 funds tracked by Wall St. Rank held Chemed as of Q3 2024.

Based on Contravisory Investment Management's 13F filing for Q3 2024, filed 9 Oct 2024.